ENU mutagenesis to identify targets for host-directed therapy against malaria.

Funding Activity

Website
http://grants.uberresearch.com/501100000925/http://purl.org/au-research/grants/nhmrc/605524/Identifying-novel-therapies-against-malaria

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Malaria kills up to one million people annually, mainly children and pregnant women. The drugs that are used to treat malaria are becoming useless due to the malarial parasite developing resistance to these drugs. We are looking at a totally new way of developing drugs that target molecules in humans , depriving the parasites of crucial factors. By using this approach, the malaria parasite will be unable to develop resistance to these new drugs and millions of lives may be saved.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $660,175.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Genetics not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Chemotherapy | Drug Resistance | Drug resistance | Gene Mapping | Malaria | Mouse Genetics | N-ethyl-N-nitrosourea (ENU) | PGP3

Related Links